Advertisement
Screener

Codiak BioSciences, Inc. Other Income and Expense

Codiak BioSciences, Inc. Other Income and Expense

Codiak BioSciences, Inc. reported Other Income and Expense of $2.12 million for the 3-month period ending 2022-09-30, per its 10-Q filed 2022-11-03.

Discontinued › Income Statement › Other Income

us-gaap:NonoperatingIncomeExpense · last filed 2022-11-03

  • Codiak BioSciences, Inc. nonoperating income (expense) for the quarter ending 2022-09-30 was $2.12M.
  • Codiak BioSciences, Inc. nonoperating income (expense) for the quarter ending 2022-06-30 was $242.00K.
  • Codiak BioSciences, Inc. nonoperating income (expense) for the quarter ending 2022-03-31 was $223.00K.
  • Codiak BioSciences, Inc. nonoperating income (expense) for the quarter ending 2021-12-31 was $33.30M.
  • Codiak BioSciences, Inc. nonoperating income (expense) for fiscal 2021 was $32.39M.
  • Codiak BioSciences, Inc. nonoperating income (expense) for fiscal 2020 was -$747.00K, a 134.08% decline from fiscal 2019.
  • Codiak BioSciences, Inc. nonoperating income (expense) for fiscal 2019 was $2.19M.
Period endNonoperating Income (Expense) 3 monthNonoperating Income (Expense) 6 monthNonoperating Income (Expense) 9 monthNonoperating Income (Expense) 12 month
2022-09-30$2.12M
10-Q · filed 2022-11-03
$2.36M
derived: sum of 2 quarters · filed 2022-11-03
$2.58M
10-Q · filed 2022-11-03
$35.88M
derived: sum of 4 quarters · filed 2022-11-03
2022-06-30$242.00K
10-Q · filed 2022-08-04
$464.00K
10-Q · filed 2022-08-04
$33.77M
derived: sum of 3 quarters · filed 2022-08-04
$33.56M
derived: sum of 4 quarters · filed 2022-11-03
2022-03-31$223.00K
10-Q · filed 2022-05-05
$33.52M
derived: sum of 2 quarters · filed 2022-05-05
$33.32M
derived: sum of 3 quarters · filed 2022-11-03
$32.98M
derived: sum of 4 quarters · filed 2022-11-03
2021-12-31$33.30M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10
$33.10M
derived: sum of 2 quarters · filed 2022-11-03
$32.75M
derived: sum of 3 quarters · filed 2022-11-03
$32.39M
10-K · filed 2022-03-10
2021-09-30-$206.00K
10-Q · filed 2022-11-03
-$549.00K
derived: sum of 2 quarters · filed 2022-11-03
-$910.00K
10-Q · filed 2022-11-03
-$1.26M
derived: sum of 4 quarters · filed 2022-11-03
2021-06-30-$343.00K
10-Q · filed 2022-08-04
-$704.00K
10-Q · filed 2022-08-04
-$1.05M
derived: sum of 3 quarters · filed 2022-08-04
-$1.32M
derived: sum of 4 quarters · filed 2022-08-04
2021-03-31-$361.00K
10-Q · filed 2022-05-05
-$711.00K
derived: sum of 2 quarters · filed 2022-05-05
-$976.00K
derived: sum of 3 quarters · filed 2022-05-05
-$1.10M
derived: sum of 4 quarters · filed 2022-05-05
2020-12-31-$350.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10
-$615.00K
derived: sum of 2 quarters · filed 2022-03-10
-$735.00K
derived: sum of 3 quarters · filed 2022-03-10
-$747.00K
10-K · filed 2022-03-10
2020-09-30-$265.00K
10-Q · filed 2021-11-04
-$385.00K
derived: sum of 2 quarters · filed 2021-11-04
-$397.00K
10-Q · filed 2021-11-04
-$225.00K
derived: sum of 4 quarters · filed 2021-11-04
2020-06-30-$120.00K
10-Q · filed 2021-08-05
-$132.00K
10-Q · filed 2021-08-05
$40.00K
derived: sum of 3 quarters · filed 2021-08-05
$607.00K
derived: sum of 4 quarters · filed 2021-08-05
2020-03-31-$12.00K
10-Q · filed 2021-05-06
$160.00K
derived: sum of 2 quarters · filed 2021-05-06
$727.00K
derived: sum of 3 quarters · filed 2021-05-06
2019-12-31$172.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-17
$739.00K
derived: sum of 2 quarters · filed 2021-03-17
$2.19M
10-K · filed 2021-03-17
2019-09-30$567.00K
10-Q · filed 2020-11-19
$2.02M
10-Q · filed 2020-11-19